Respiratory Syncytial Virus (RSV): progress, challenges and outcomes
Created 06 Mar 2024
| 6 articles
Respiratory Syncytial Virus (RSV) can lead to symptoms akin to the common cold or winter flu, runny nose, cough, fever and so on. During the COVID-19 pandemic, a dip in RSV infections was noted in the United States, meaning the pandemic could have influenced the transmission of RSV during this period. This Thematic Series considers how infection rates prior to the pandemic differ from to those from 2020 onwards. The Series focuses on the factors leading to these changes, the mortality rates for co-morbid COVID-19 and RSV, and the body’s immunity response.